Parkinson's Disease Trial, Recruiting NCT07390825 Sponsor: Ankara City Hospital Bilkent Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07390825
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Idiopathic (typical) Parkinson's Disease and are between 40 and 80 years old, and you agree to take part in the treatment.
  • You are regularly seen by a neurologist and your Parkinson's medications have stayed the same for at least the last 3 months.
  • Your Parkinson's is at a mild to moderate stage (stage 1 to 3 on a standard Parkinson's staging scale — confirm with trial site if unsure of your stage).
  • You scored 24 or higher on a standard memory and thinking test called the Mini-Mental State Examination (MMSE).
  • You are able to stand upright on your own and can walk, with or without a walking aid.

Who may not be able to join:

  • You have a bone, joint, rheumatic, or other neurological condition (unrelated to Parkinson's) that affects how you move or function.
  • Your Parkinson's medications have been changed or adjusted in the last 3 months.
  • You have been diagnosed with an atypical or unusual form of Parkinson's Disease (not the standard type).
  • You have a visual impairment or significant problems with your eyesight.
  • You have been diagnosed with dementia.
  • You have a serious heart or breathing condition that is not well controlled.
  • You have a condition called diabetes insipidus (a rare hormone-related condition — confirm with trial site).
  • You currently have an active infection anywhere in your body.
  • You have broken, damaged, or infected skin.
  • You are sensitive or have had reactions to inhaled steam or chemicals found in water.
  • You have a history of epilepsy (seizures) or asthma.
  • You experience loss of bladder or bowel control.
  • You do not wish to take part or do not give your consent to the treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Halil Uçan, Prof. Doctor, Bilkent City Hospital

Phone: +905059025460

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ankara City Hospital Bilkent
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
1 August 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Parkinson's Disease Questionnaire-39

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov